|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM290246725 |
| 003 |
DE-627 |
| 005 |
20231225064321.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2019 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2018.10.019
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0967.xml
|
| 035 |
|
|
|a (DE-627)NLM290246725
|
| 035 |
|
|
|a (NLM)30391351
|
| 035 |
|
|
|a (PII)S1521-6616(18)30324-3
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Cuvelier, Geoffrey D E
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical presentation, immunologic features, and hematopoietic stem cell transplant outcomes for IKBKB immune deficiency
|
| 264 |
|
1 |
|c 2019
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 20.04.2020
|
| 500 |
|
|
|a Date Revised 20.04.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2018 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a IKBKB immune deficiency is a rare but life-threatening primary immunodeficiency disorder, involving activation defects in adaptive and innate immunity. We present sixteen cases of a homozygous IKBKB mutation (c.1292dupG) in infants characterized by early-onset bacterial, viral, fungal and Mycobacterial infections. In most cases, T- and B-cells were quantitatively normal, but phenotypically naïve, with severe hypogammaglobulinemia. T-cell receptor excision circles were normal, meaning newborn screening by TREC analysis would miss IKBKB cases. Although IKBKB immune deficiency does not meet traditional laboratory based definitions for SCID, this combined immune deficiency appears to be at least as profound. Urgent HSCT, performed in eight patients, remains the only known curative therapy, although only three patients are survivors. Ongoing infections after transplant remain a concern, and may be due to combinations of poor social determinants of health, secondary graft failure, and failure of HSCT to replace non-hematopoietic cells important in immune function and dependent upon IKK/NF-κB pathways
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Combined Immune Deficiency
|
| 650 |
|
4 |
|a Hematopoietic Stem Cell Transplant
|
| 650 |
|
4 |
|a IKBKB
|
| 650 |
|
4 |
|a IKK/NF-κB
|
| 650 |
|
4 |
|a IKKβ (IKK2)
|
| 650 |
|
7 |
|a I-kappa B Kinase
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.10
|2 NLM
|
| 650 |
|
7 |
|a IKBKB protein, human
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.10
|2 NLM
|
| 700 |
1 |
|
|a Rubin, Tamar S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Junker, Anne
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sinha, Roona
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rosenberg, Alan M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wall, Donna A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Schroeder, Marlis L
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 205(2019) vom: 05. Aug., Seite 138-147
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:205
|g year:2019
|g day:05
|g month:08
|g pages:138-147
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2018.10.019
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 205
|j 2019
|b 05
|c 08
|h 138-147
|